Clinical Next-Generation Sequencing (NGS) Data Analysis Market Snapshot

The global clinical next-generation sequencing (NGS) data analysis market enjoys a valuation of US$ 2.3 Billion in 2022, and it is further projected to expand at a CAGR of 17.4% over the forecasted years. According to a recent study by Future Market Insights, NGS data analysis & sequencing services are leading the market with a share of about 41.8% in the year 2022, within the global market.

Market Outlook:

Data Points Market Insights
Market Value 2022 US$ 2.3 Billion
Market Value 2033 US$ 13.1 Billion
CAGR 2023 to 2033 17.4%
Market Share of Top 5 Countries 66.0%
Key Market Players Agilent Technologies, Inc., Illumina, Inc., Thermo Fisher Scientific, Inc., Eurofins Scientific, BGI Group, Qiagen, Roche Diagnostics, DNA Star, Inc., Bio-Rad Laboratories, Inc., Congenica Ltd., Theragen Etex Inc., PerkinElmer, Inc., Partek Inc., Oxford Nanopore Technologies PLC., Pacific Biosciences of California, Inc., Golden Helix, Inc., and BioDatomics.

In order to determine DNA/RNA sequences for the complete genome or to examine a particular region of interest connected to diseases or biological processes, a breakthrough method called next-generation sequencing is being developed. The market for clinical next-generation sequencing data analysis has expanded because of the demand for comprehensive information on genomic sequences.

The nucleotide sequence of entire genomes or specific portions of DNA or RNA can be ascertained using NGS data analysis tools. Sequence alignment, alignment visualisation, gene prediction, and variation analysis tools are a few of the NGS data analysis tools.

With its extremely high throughput, scalability and speed, next-generation sequencing (NGS) is a massively parallel sequencing technology. The sequencers utilised in the sequencing process are known as next-generation sequencing platforms. The NGS platforms contribute to the vast scale delivery of exceptionally high data quality and accuracy.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Sales Analysis of Clinical Next-Generation Sequencing (NGS) Data Analysis Market from 2014 to 2022 Vs Market Outlook for 2023 to 2033

The global sales of the market are anticipated to rise at a CAGR of 11.9% between 2014 and 2022, owing to the rising prevalence of various chronic diseases.

The global market holds around 39.2% share of the overall global DNA sequencing market with a value of around US$ 5.8 Billion, in 2022.

One of the key factors propelling growth of the market in the coming years is the increasing number of life sciences companies. With the expansion of the life sciences industry, numerous small and medium-sized companies are entering the market with novel product offerings and more complex technology to set themselves apart from competitors. Companies conduct extensive research in order to provide novel products.

Owing to the above-mentioned factors, the global market is expected to grow at a prominent pace, and reach a valuation of around US$ 13.1 billion during the year 2033.

What are the Key Opportunities for the Manufacturers Operating in the Global Market?

Technological advances in genomic-based bioinformatics tools are providing many opportunities for market growth. A sizable amount of genetic data is now accessible on web-based bioinformatics platforms because of recent advancements in bioinformatics research and technologies.

Research analysts or data scientists can now compare and assess the quality of their sequencing run, assess in-line control validation, assign sequences to known regions, and characterise other sequences that reflect certain immune receptor clones.

One can infer information about unique immune response traits, their associated current illness scenario, and the consequences of therapeutic antigen presentation by understanding the abundance of particular clones and how they fluctuate in relation to treatment response and disease progression.

Performing tests on relatively tiny samples allows for efficient analysis from easily available material without the need for extra sampling, which is another benefit of genomic-based analyses.

For instance, Illumina released a BaseSpace Informatics Suite in 2014 that enables a lab to follow genetic tests even if it has no genomic computing infrastructure of its own. The suite's extensive software library makes it simple to carry out ordinary data analysis of sequences.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Factors Restraining Demand within the Global Market?

In undeveloped countries, there is less access to modern infrastructure. Therefore, the only alternative for using these technologies to carry out immune repertoire sequencing experiments is outsourcing. Additionally, some outsourcing companies in poor countries are known for offering inferior services.

To be precise, these companies do not actually offer the sequencing service. Instead, they serve as local service providers for companies with operations abroad. They submit samples to companies in other countries for sequencing, and then they get the results. Poor service delivery occurs during the transit and sequence process time due to a number of variables, including inappropriate sample handling, transportation issues, and lengthy wait periods.

Overall, the process is quite costly, takes a long time, and often takes several months to provide the desired outcomes. Therefore, low quality of outsourcing services is likely to limit the overall market growth.

Country-wise Insights

What Makes the USA a Large Market for Clinical Next-Generation Sequencing (NGS) Data Analysis?

The USA dominates the North American region with a total market share of around 89.1% in 2022 and is expected to continue to experience the same growth throughout the forecast period. The regional dominance is attributed to increasing cancer cases in the region. For instance, according to American Cancer Society, in 2022, 1.9 million new cancer cases were diagnosed and around 609,360-cancer related deaths in the United States were estimated.

Various FDA approvals and rapid technological developments have helped in the growth of this region.

What is the Scenario of Germany within the Clinical Next-Generation Sequencing (NGS) Data Analysis Market Space?

Germany held a market share of around 32.1% in 2022 in the European clinical next-generation sequencing (NGS) data analysis market, owing to increasing collaboration, acquisition, and mergers by the market players in the region. For instance, in April 2022, Illumina and Hannover Medical School signed a contract to evaluate the use of rapid whole-genome sequencing in critically ill kids who are thought to have a hereditary or uncommon condition.

Also, the region is heavily focused on research and developments in the pharmaceutical industry, biotechnological industry, and novel technological developments, which is boosting the market for clinical next-generation sequencing (NGS) data analysis.

What is the Outlook of China in the Clinical Next-Generation Sequencing (NGS) Data Analysis Market?

China holds a market share of 56.3%, with a market value of US$ 107.7 Million in the East Asia clinical next-generation sequencing (NGS) data analysis market in 2022. Increasing prevalence of autism a disorder that causes substantial distress is the main factor stimulating the regional market. For instance, according to NHC Study Team. Prevalence of Autism Spectrum Disorder in China: A Nationwide Multi-center Population-based Study among Children Aged 6 to 12 Years. Neurosci Bull. 2020, out of 142,086 around 363 children were confirmed having autism spectrum disorder.

Disruptive variations in the genome's protein-coding regions can be found with next-generation sequencing (NGS). These NGS techniques changed the search for the ASD gene in conjunction with big cohorts and new statistical techniques. In order to understand the neurobiological effects of altering these ASD-associated genes, functional genetic data, such as gene expression, is greatly benefited from the use of NGS techniques.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Which Clinical Next-Generation Sequencing (NGS) Data Analysis Solution and Services is driving the Market Growth?

NGS data analysis & sequencing services are expected to give high growth at a CAGR of 15.2% between 2023 and 2033. This is because services for NGS data analysis are readily available and reasonably priced. For companies with inadequate infrastructure, this service offers management and interpretation support.

For instance, ArrayGen Technologies provides a broad range of NGS data processing services in the fields of cancer genomics, crop biotechnology, personalised medicine, and disease association research. A comparable selection of NGS data analysis services is offered by ThermoFisher Scientific. The segment growth is attributable to the readily accessible, reasonably priced NGS data analysis services.

Which Technology is Widely Adopted in the Global Market?

Sequencing by synthesis (SBS) is widely adopted with the market share of 42.7% in the global market in 2022. DNA polymerases and dNTPs are employed to replicate (or synthesise) the strand that has to be sequenced in the sequencing by synthesis technique.

De novo sequencing, long-insert paired-end reads for fast sequence assembly, and other applications are provided by SBS technology as well as to short-insert coupled reads for high-resolution genomic studies. Combining short inserts with long reads improves the ability to fully characterise any genome. The segment increase is attributable to SBS's affirmative technology elements.

Which Application is Widely in Use within the Global Market?

Medical research in global clinical next-generation sequencing data analysis market is widely used, holding a market share of 39.6% in the global market in 2022. This segment is predicted to increase significantly because of the use of NGS for the study of tumour heterogeneity, the identification of new genes connected to cancer, and the finding of changes related to carcinogenesis.

The Genomic Medicine Service of the National Health Service in the United Kingdom has adopted a sequencing-based method for the clinical investigation of cancer with an unknown cause and the evaluation of potential treatments. Increase in such sequencing-based approaches for various research is anticipated to boost the segment growth.

Which End User Benefits the Most from the Sales within the Market?

Academic institutes & research centres hold a market share of 37.7% during the year 2022. Increasing adoption of NGS software platforms the factors attributed for segment growth. Several academic and research organisations now use more NGS software platforms for their projects requiring data interpretation because of falling NGS technology costs.

A further factor that is expected to promote income production in this sector is the gradual increase in the number of qualified employees handling software and computational tools in research institutions. Several institutions provide on-site bioinformatics training programmes and courses with the goal of improving knowledge of various sequencing data analysis options.

Competitive Landscape

Major manufacturers are striving to increase the market reach of both their key products and the solutions they offer to consumers. For instance, today's top manufacturers often offer specialised solutions based on the needs of different end users. Due to the high level of competition in the market, many top competitors are heavily concentrating on various market consolidation operations like merger, acquisition, supply distribution partnerships, and the introduction of new products.

Instances of important developmental strategies used among market participants in the clinical next-generation sequencing (NGS) data analysis market are presented below:

  • In 2022, llumina unveiled a new sequencing system and a cooperation with Roche and Software Suite, to speed up the use of genomics.
  • In 2021, Roche introduced the AVENIO Edge System to develop next-generation sequencing (NGS) technology.

Similarly, the team at Future Market Insights has tracked recent developments related to companies within the clinical next-generation sequencing (NGS) data analysis space. These are available in the full report.

Report Scope as per Clinical Next-Generation Sequencing (NGS) Data Analysis Industry Analysis

Attribute Details
Historical Data Available for 2014 to 2022
Forecast Data 2023 to 2033
Market Analysis US$ Million for Value
Key Regions Covered North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East & Africa
Key Countries Covered The USA, Canada, Brazil, Mexico, Argentina, The United Kingdom, Germany, Italy, Russia, Spain, France, Benelux, Nordics Countries, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries, North Africa and South Africa
Key Market Segments Covered Solution and Services, Technology, Application, End User, and Region
Key Companies Profiled
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Eurofins Scientific
  • BGI Group
  • Qiagen
  • Roche Diagnostics
  • DNAStar, Inc.
  • Bio-Rad Laboratories, Inc.
  • Congenica Ltd.
  • Theragen Etex Inc.
  • PerkinElmer, Inc.
  • Partek Inc.
  • Oxford Nanopore Technologies PLC.
  • Pacific Biosciences of California, Inc.
  • Golden Helix, Inc.
  • BioDatomics
  • PierianDx
Pricing Available upon Request

Key Market Segments Covered in the Clinical Next-Generation Sequencing (NGS) Data Analysis Industry Research

Solution and Services:

  • NGS Data Analysis Tools
    • Sequence Alignment Tools
    • Alignment Visualization Tools
    • Gene Prediction Tools
    • Variant Analysis Tools
    • Others
  • Platforms
    • Next-Generation Sequencing (NGS) Platforms
    • Clinical Informatics Platforms
    • Others
  • NGS Data Analysis & Sequencing Services
    • Whole-Genome Sequencing (WGS)
    • Whole Exome Sequencing (WES)
    • Comprehensive genomic profiling (CGP)
    • Custom Panels
    • RNA Sequencing
    • Other Sequencing Services
  • NGS Storage, Management & Cloud Computing Platform

Technology:

  • Sequencing by Synthesis (SBS)
  • Nanopore Sequencing
  • Single-Molecule Real-Time (SMRT) Sequencing
  • Others

Application:

  • Diagnostics
  • Drug Discovery & Designing
  • Medical Research
  • Others

End User:

  • Hospitals & Clinics
  • Academic Institutes & Research Centers
  • Biotechnology Companies
  • Life Science Technology Vendors
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

Frequently Asked Questions

What is the Valuation of Currently Available Clinical Next-Generation Sequencing (NGS) Data Analysis Services?

The global clinical next-generation sequencing (NGS) data analysis market value was US$ 2.3 billion in 2022.

Which is the Leading End User Segment for the overall Market?

In 2022, the revenue generated from sales to academic institutes and research centre was 37.7% of the total.

What is the Share of China in the Global Clinical NGS Data Analysis Market?

The China market was valued at US$ 107.7 million that is 56.3% of the global market in 2022.

Based on Solution Which is the Fastest Growing Segment?

NGS data analysis & sequencing services segment is forecasted to grow at 15.2% CAGR through 2033.

Which is the Most Profoundly Used Technology by the Market Players?

Sequencing by synthesis (SBS) technology is widely adopted and had 42.7% market share in 2022.

Table of Content

1. Executive Summary | Clinical Next-Generation Sequencing (NGS) Data Analysis Market

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply–Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Development/Innovation Trends

    3.3. Regional Trends

4. Key Success Factors

    4.1. NGS Data Analysis Tools Adoption and Usage Analysis

    4.2. Key Promotional Strategies by Manufacturers

    4.3. Regulatory Landscape

    4.4. PESTLE Analysis

    4.5. Porter’s Analysis

    4.6. Reimbursement Scenario

5. Market Background

    5.1. Macro–Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Expenditure

        5.1.3. Global DNA Sequencing Market Outlook

    5.2. Forecast Factors – Relevance & Impact

        5.2.1. Technological Advancement in NGS Sequencing Tools

        5.2.2. Growing Innovations and Wide Industry Scope

        5.2.3. Significant Developments in the Research and Biotechnology Space

        5.2.4. Investments by Various Local Players

        5.2.5. Adoption Rate of NGS Sequencing Services

        5.2.6. Key Players’ Historic Growth

        5.2.7. Growing Healthcare Expenditure

        5.2.8. Regulatory Scenario

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity

6. COVID–19 Crisis – Impact Assessment

    6.1. Impact of COVID–19: An Overview

    6.2. COVID–19 and Impact Analysis

        6.2.1. By Solution and Services

        6.2.2. By Technology

        6.2.3. By Application

        6.2.4. By End User

        6.2.5. By Region

    6.3. 2022 Scenario

7. Global Market Demand (in Value or Size in US$ Million) Analysis 2014 to 2022 and Forecast, 2023 to 2033

    7.1. Historical Market Value (US$ Million) Analysis, 2014 to 2022

    7.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033

        7.2.1. Y–o–Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2014 to 2022 and Forecast 2023 to 2033, By Solution and Services

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Million) Analysis By Solution and Services, 2014 to 2022

    8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Solution and Services, 2023 to 2033

        8.3.1. NGS Data Analysis Tools

            8.3.1.1. Sequence Alignment Tools

            8.3.1.2. Alignment Visualization Tools

            8.3.1.3. Gene Prediction Tools

            8.3.1.4. Variant Analysis Tools

            8.3.1.5. Others

        8.3.2. Platforms

            8.3.2.1. Next–Generation Sequencing (NGS) Platforms

            8.3.2.2. Clinical Informatics Platforms

            8.3.2.3. Others

        8.3.3. NGS Data Analysis & Sequencing Services

            8.3.3.1. Whole–Genome Sequencing (WGS)

            8.3.3.2. Whole Exome Sequencing (WES)

            8.3.3.3. Comprehensive genomic profiling (CGP)

            8.3.3.4. Custom Panels

            8.3.3.5. RNA Sequencing

            8.3.3.6. Other Sequencing Services

        8.3.4. NGS Storage, Management & Cloud Computing Platform

    8.4. Market Attractiveness Analysis By Solution and Services

9. Global Market Analysis 2014 to 2022 and Forecast 2023 to 2033, By Technology

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Million) By Technology, 2014 to 2022

    9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Technology, 2023 to 2033

        9.3.1. Sequencing by Synthesis (SBS)

        9.3.2. Nanopore Sequencing

        9.3.3. Single–Molecule Real–Time (SMRT) Sequencing

        9.3.4. Others

    9.4. Market Attractiveness Analysis By Technology

10. Global Market Analysis 2014 to 2022 and Forecast 2023 to 2033, By Application

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Million) By Application, 2014 to 2022

    10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033

        10.3.1. Diagnostics

        10.3.2. Drug Discovery & Designing

        10.3.3. Medical Research

        10.3.4. Others

    10.4. Market Attractiveness Analysis By Application

11. Global Market Analysis 2014 to 2022 and Forecast 2023 to 2033, By End User

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Million) By End User, 2014 to 2022

    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033

        11.3.1. Hospitals & Clinics

        11.3.2. Academic Institutes & Research Centres

        11.3.3. Biotechnology Companies

        11.3.4. Life Science Technology Vendors

        11.3.5. Others

    11.4. Market Attractiveness Analysis By End User

12. Global Market Analysis 2014 to 2022 and Forecast 2023 to 2033, By Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Million) Analysis By Region, 2014 to 2022

    12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. East Asia

        12.3.5. South Asia

        12.3.6. Oceania

        12.3.7. Middle East and Africa (MEA)

    12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2014 to 2022 and Forecast 2023 to 2033

    13.1. Introduction

    13.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2014 to 2022

    13.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        13.3.1. By Country

            13.3.1.1. USA

            13.3.1.2. Canada

        13.3.2. By Solution and Services

        13.3.3. By Technology

        13.3.4. By Application

        13.3.5. By End User

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Solution and Services

        13.4.3. By Technology

        13.4.4. By Application

        13.4.5. By End User

    13.5. Market Trends

    13.6. Key Market Participants – Intensity Mapping

    13.7. Drivers and Restraints – Impact Analysis

    13.8. Country Level Analysis & Forecast

        13.8.1. USA Market Analysis

            13.8.1.1. Introduction

            13.8.1.2. Market Analysis and Forecast by Market Taxonomy

                13.8.1.2.1. By Solution and Services

                13.8.1.2.2. By Technology

                13.8.1.2.3. By Application

                13.8.1.2.4. By End User

        13.8.2. Canada Market Analysis

            13.8.2.1. Introduction

            13.8.2.2. Market Analysis and Forecast by Market Taxonomy

                13.8.2.2.1. By Solution and Services

                13.8.2.2.2. By Technology

                13.8.2.2.3. By Application

                13.8.2.2.4. By End User

14. Latin America Market Analysis 2014 to 2022 and Forecast 2023 to 2033

    14.1. Introduction

    14.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2014 to 2022

    14.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        14.3.1. By Country

            14.3.1.1. Mexico

            14.3.1.2. Brazil

            14.3.1.3. Argentina

            14.3.1.4. Rest of Latin America

        14.3.2. By Solution and Services

        14.3.3. By Technology

        14.3.4. By Application

        14.3.5. By End User

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Solution and Services

        14.4.3. By Technology

        14.4.4. By Application

        14.4.5. By End User

    14.5. Market Trends

    14.6. Key Market Participants – Intensity Mapping

    14.7. Drivers and Restraints – Impact Analysis

    14.8. Country Level Analysis & Forecast

        14.8.1. Mexico Market Analysis

            14.8.1.1. Introduction

            14.8.1.2. Market Analysis and Forecast by Market Taxonomy

                14.8.1.2.1. By Solution and Services

                14.8.1.2.2. By Technology

                14.8.1.2.3. By Application

                14.8.1.2.4. By End User

        14.8.2. Brazil Market Analysis

            14.8.2.1. Introduction

            14.8.2.2. Market Analysis and Forecast by Market Taxonomy

                14.8.2.2.1. By Solution and Services

                14.8.2.2.2. By Technology

                14.8.2.2.3. By Application

                14.8.2.2.4. By End User

        14.8.3. Argentina Market Analysis

            14.8.3.1. Introduction

            14.8.3.2. Market Analysis and Forecast by Market Taxonomy

                14.8.3.2.1. By Solution and Services

                14.8.3.2.2. By Technology

                14.8.3.2.3. By Application

                14.8.3.2.4. By End User

15. Europe Market Analysis 2014 to 2022 and Forecast 2023 to 2033

    15.1. Introduction

    15.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2014 to 2022

    15.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        15.3.1. By Country

            15.3.1.1. United Kingdom

            15.3.1.2. Germany

            15.3.1.3. France

            15.3.1.4. Italy

            15.3.1.5. Spain

            15.3.1.6. BENELUX

            15.3.1.7. Russia

            15.3.1.8. Rest of Europe

        15.3.2. By Solution and Services

        15.3.3. By Technology

        15.3.4. By Application

        15.3.5. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Solution and Services

        15.4.3. By Technology

        15.4.4. By Application

        15.4.5. By End User

    15.5. Key Market Participants – Intensity Mapping

    15.6. Drivers and Restraints – Impact Analysis

    15.7. Country Level Analysis & Forecast

        15.7.1. U.K. Market Analysis

            15.7.1.1. Introduction

            15.7.1.2. Market Analysis and Forecast by Market Taxonomy

                15.7.1.2.1. By Solution and Services

                15.7.1.2.2. By Technology

                15.7.1.2.3. By Application

                15.7.1.2.4. By End User

        15.7.2. Germany Market Analysis

            15.7.2.1. Introduction

            15.7.2.2. Market Analysis and Forecast by Market Taxonomy

                15.7.2.2.1. By Solution and Services

                15.7.2.2.2. By Technology

                15.7.2.2.3. By Application

                15.7.2.2.4. By End User

        15.7.3. France Market Analysis

            15.7.3.1. Introduction

            15.7.3.2. Market Analysis and Forecast by Market Taxonomy

                15.7.3.2.1. By Solution and Services

                15.7.3.2.2. By Technology

                15.7.3.2.3. By Application

                15.7.3.2.4. By End User

        15.7.4. Italy Market Analysis

            15.7.4.1. Introduction

            15.7.4.2. Market Analysis and Forecast by Market Taxonomy

                15.7.4.2.1. By Solution and Services

                15.7.4.2.2. By Technology

                15.7.4.2.3. By Application

                15.7.4.2.4. By End User

        15.7.5. Spain Market Analysis

            15.7.5.1. Introduction

            15.7.5.2. Market Analysis and Forecast by Market Taxonomy

                15.7.5.2.1. By Solution and Services

                15.7.5.2.2. By Technology

                15.7.5.2.3. By Application

                15.7.5.2.4. By End User

        15.7.6. BENELUX Market Analysis

            15.7.6.1. Introduction

            15.7.6.2. Market Analysis and Forecast by Market Taxonomy

                15.7.6.2.1. By Solution and Services

                15.7.6.2.2. By Technology

                15.7.6.2.3. By Application

                15.7.6.2.4. By End User

        15.7.7. Nordic Countries Market Analysis

            15.7.7.1. Introduction

            15.7.7.2. Market Analysis and Forecast by Market Taxonomy

                15.7.7.2.1. By Solution and Services

                15.7.7.2.2. By Technology

                15.7.7.2.3. By Application

                15.7.7.2.4. By End User

        15.7.8. Russia Market Analysis

            15.7.8.1. Introduction

            15.7.8.2. Market Analysis and Forecast by Market Taxonomy

                15.7.8.2.1. By Solution and Services

                15.7.8.2.2. By Technology

                15.7.8.2.3. By Application

                15.7.8.2.4. By End User

16. East Asia Market Analysis 2014 to 2022 and Forecast 2023 to 2033

    16.1. Introduction

    16.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2014 to 2022

    16.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        16.3.1. By Country

            16.3.1.1. China

            16.3.1.2. Japan

            16.3.1.3. South Korea

        16.3.2. By Solution and Services

        16.3.3. By Technology

        16.3.4. By Application

        16.3.5. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Solution and Services

        16.4.3. By Technology

        16.4.4. By Application

        16.4.5. By End User

    16.5. Key Market Participants – Intensity Mapping

    16.6. Drivers and Restraints – Impact Analysis

    16.7. Country Level Analysis & Forecast

        16.7.1. China Market Analysis

            16.7.1.1. Introduction

            16.7.1.2. Market Analysis and Forecast by Market Taxonomy

                16.7.1.2.1. By Solution and Services

                16.7.1.2.2. By Technology

                16.7.1.2.3. By Application

                16.7.1.2.4. By End User

        16.7.2. Japan Market Analysis

            16.7.2.1. Introduction

            16.7.2.2. Market Analysis and Forecast by Market Taxonomy

                16.7.2.2.1. By Solution and Services

                16.7.2.2.2. By Technology

                16.7.2.2.3. By Application

                16.7.2.2.4. By End User

        16.7.3. South Korea Market Analysis

            16.7.3.1. Introduction

            16.7.3.2. Market Analysis and Forecast by Market Taxonomy

                16.7.3.2.1. By Solution and Services

                16.7.3.2.2. By Technology

                16.7.3.2.3. By Application

                16.7.3.2.4. By End User

17. South Asia Market Analysis 2014 to 2022 and Forecast 2023 to 2033

    17.1. Introduction

    17.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2014 to 2022

    17.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        17.3.1. By Country

            17.3.1.1. India

            17.3.1.2. Malaysia

            17.3.1.3. Thailand

            17.3.1.4. Indonesia

            17.3.1.5. Rest of South Asia

        17.3.2. By Solution and Services

        17.3.3. By Technology

        17.3.4. By Application

        17.3.5. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Solution and Services

        17.4.3. By Technology

        17.4.4. By Application

        17.4.5. By End User

    17.5. Key Market Participants – Intensity Mapping

    17.6. Drivers and Restraints – Impact Analysis

    17.7. Country Level Analysis & Forecast

        17.7.1. India Market Analysis

            17.7.1.1. Introduction

            17.7.1.2. Market Analysis and Forecast by Market Taxonomy

                17.7.1.2.1. By Solution and Services

                17.7.1.2.2. By Technology

                17.7.1.2.3. By Application

                17.7.1.2.4. By End User

        17.7.2. Malaysia Market Analysis

            17.7.2.1. Introduction

            17.7.2.2. Market Analysis and Forecast by Market Taxonomy

                17.7.2.2.1. By Solution and Services

                17.7.2.2.2. By Technology

                17.7.2.2.3. By Application

                17.7.2.2.4. By End User

        17.7.3. Thailand Market Analysis

            17.7.3.1. Introduction

            17.7.3.2. Market Analysis and Forecast by Market Taxonomy

                17.7.3.2.1. By Solution and Services

                17.7.3.2.2. By Technology

                17.7.3.2.3. By Application

                17.7.3.2.4. By End User

        17.7.4. Indonesia Market Analysis

            17.7.4.1. Introduction

            17.7.4.2. Market Analysis and Forecast by Market Taxonomy

                17.7.4.2.1. By Solution and Services

                17.7.4.2.2. By Technology

                17.7.4.2.3. By Application

                17.7.4.2.4. By End User

18. Oceania Market 2014 to 2022 and Forecast 2023 to 2033

    18.1. Introduction

    18.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2014 to 2022

    18.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        18.3.1. By Country

            18.3.1.1. Australia

            18.3.1.2. New Zealand

        18.3.2. By Solution and Services

        18.3.3. By Technology

        18.3.4. By Application

        18.3.5. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Solution and Services

        18.4.3. By Technology

        18.4.4. By Application

        18.4.5. By End User

    18.5. Key Market Participants – Intensity Mapping

    18.6. Drivers and Restraints – Impact Analysis

    18.7. Country Level Analysis & Forecast

        18.7.1. Australia Market Analysis

            18.7.1.1. Introduction

            18.7.1.2. Market Analysis and Forecast by Market Taxonomy

                18.7.1.2.1. By Solution and Services

                18.7.1.2.2. By Technology

                18.7.1.2.3. By Application

                18.7.1.2.4. By End User

        18.7.2. New Zealand Market Analysis

            18.7.2.1. Introduction

            18.7.2.2. Market Analysis and Forecast by Market Taxonomy

                18.7.2.2.1. By Solution and Services

                18.7.2.2.2. By Technology

                18.7.2.2.3. By Application

                18.7.2.2.4. By End User

19. Middle East and Africa (MEA) Market Analysis 2014 to 2022 and Forecast 2023 to 2033

    19.1. Introduction

    19.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2014 to 2022

    19.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033

        19.3.1. By Country

            19.3.1.1. GCC Countries

            19.3.1.2. Türkiye

            19.3.1.3. South Africa

            19.3.1.4. Rest of Middle East and Africa

        19.3.2. By Solution and Services

        19.3.3. By Technology

        19.3.4. By Application

        19.3.5. By End User

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Solution and Services

        19.4.3. By Technology

        19.4.4. By Application

        19.4.5. By End User

    19.5. Key Market Participants – Intensity Mapping

    19.6. Drivers and Restraints – Impact Analysis

    19.7. Country Level Analysis & Forecast

        19.7.1. GCC Countries Market Analysis

            19.7.1.1. Introduction

            19.7.1.2. Market Analysis and Forecast by Market Taxonomy

                19.7.1.2.1. By Solution and Services

                19.7.1.2.2. By Technology

                19.7.1.2.3. By Application

                19.7.1.2.4. By End User

        19.7.2. Türkiye Market Analysis

            19.7.2.1. Introduction

            19.7.2.2. Market Analysis and Forecast by Market Taxonomy

                19.7.2.2.1. By Solution and Services

                19.7.2.2.2. By Technology

                19.7.2.2.3. By Application

                19.7.2.2.4. By End User

        19.7.3. North Africa Market Analysis

            19.7.3.1. Introduction

            19.7.3.2. Market Analysis and Forecast by Market Taxonomy

                19.7.3.2.1. By Solution and Services

                19.7.3.2.2. By Technology

                19.7.3.2.3. By Application

                19.7.3.2.4. By End User

        19.7.4. South Africa Market Analysis

            19.7.4.1. Introduction

            19.7.4.2. Market Analysis and Forecast by Market Taxonomy

                19.7.4.2.1. By Solution and Services

                19.7.4.2.2. By Technology

                19.7.4.2.3. By Application

                19.7.4.2.4. By End User

20. Market Structure Analysis

    20.1. Market Analysis by Tier of Companies

    20.2. Market Share Analysis of Top Players (%)

    20.3. Market Presence Analysis

        20.3.1. By Regional Footprint of Players

        20.3.2. Product Footprint of Players

        20.3.3. Channel Footprint of Players

21. Competition Analysis

    21.1. Competition Dashboard

    21.2. Competition Benchmarking

    21.3. Competition Deep Dive

        21.3.1. Agilent Technologies, Inc.

            21.3.1.1. Overview

            21.3.1.2. Product Portfolio

            21.3.1.3. Key Financials

            21.3.1.4. SWOT Analysis

            21.3.1.5. Key Developments

            21.3.1.6. Sales Footprint

            21.3.1.7. Strategy Overview

        21.3.2. Illumina, Inc.

            21.3.2.1. Overview

            21.3.2.2. Product Portfolio

            21.3.2.3. Key Financials

            21.3.2.4. SWOT Analysis

            21.3.2.5. Key Developments

            21.3.2.6. Sales Footprint

            21.3.2.7. Strategy Overview

        21.3.3. Thermo Fisher Scientific, Inc.

            21.3.3.1. Overview

            21.3.3.2. Product Portfolio

            21.3.3.3. Key Financials

            21.3.3.4. SWOT Analysis

            21.3.3.5. Key Developments

            21.3.3.6. Sales Footprint

            21.3.3.7. Strategy Overview

        21.3.4. Eurofins Scientific

            21.3.4.1. Overview

            21.3.4.2. Product Portfolio

            21.3.4.3. Key Financials

            21.3.4.4. SWOT Analysis

            21.3.4.5. Key Developments

            21.3.4.6. Sales Footprint

            21.3.4.7. Strategy Overview

        21.3.5. BGI Group

            21.3.5.1. Overview

            21.3.5.2. Product Portfolio

            21.3.5.3. Key Financials

            21.3.5.4. SWOT Analysis

            21.3.5.5. Key Developments

            21.3.5.6. Sales Footprint

            21.3.5.7. Strategy Overview

        21.3.6. Qiagen

            21.3.6.1. Overview

            21.3.6.2. Product Portfolio

            21.3.6.3. Key Financials

            21.3.6.4. SWOT Analysis

            21.3.6.5. Key Developments

            21.3.6.6. Sales Footprint

            21.3.6.7. Strategy Overview

        21.3.7. Roche Diagnostics

            21.3.7.1. Overview

            21.3.7.2. Product Portfolio

            21.3.7.3. Key Financials

            21.3.7.4. SWOT Analysis

            21.3.7.5. Key Developments

            21.3.7.6. Sales Footprint

            21.3.7.7. Strategy Overview

        21.3.8. DNAStar, Inc.

            21.3.8.1. Overview

            21.3.8.2. Product Portfolio

            21.3.8.3. Key Financials

            21.3.8.4. SWOT Analysis

            21.3.8.5. Key Developments

            21.3.8.6. Sales Footprint

            21.3.8.7. Strategy Overview

        21.3.9. Bio–Rad Laboratories, Inc.

            21.3.9.1. Overview

            21.3.9.2. Product Portfolio

            21.3.9.3. Key Financials

            21.3.9.4. SWOT Analysis

            21.3.9.5. Key Developments

            21.3.9.6. Sales Footprint

            21.3.9.7. Strategy Overview

        21.3.10. Congenica Ltd.

            21.3.10.1. Overview

            21.3.10.2. Product Portfolio

            21.3.10.3. Key Financials

            21.3.10.4. SWOT Analysis

            21.3.10.5. Key Developments

            21.3.10.6. Sales Footprint

            21.3.10.7. Strategy Overview

        21.3.11. Theragen Etex Inc.

            21.3.11.1. Overview

            21.3.11.2. Product Portfolio

            21.3.11.3. Key Financials

            21.3.11.4. SWOT Analysis

            21.3.11.5. Key Developments

            21.3.11.6. Sales Footprint

            21.3.11.7. Strategy Overview

        21.3.12. PerkinElmer, Inc.

            21.3.12.1. Overview

            21.3.12.2. Product Portfolio

            21.3.12.3. Key Financials

            21.3.12.4. SWOT Analysis

            21.3.12.5. Key Developments

            21.3.12.6. Sales Footprint

            21.3.12.7. Strategy Overview

        21.3.13. Partek Inc.

            21.3.13.1. Overview

            21.3.13.2. Product Portfolio

            21.3.13.3. Key Financials

            21.3.13.4. SWOT Analysis

            21.3.13.5. Key Developments

            21.3.13.6. Sales Footprint

            21.3.13.7. Strategy Overview

        21.3.14. Oxford Nanopore Technologies PLC.

            21.3.14.1. Overview

            21.3.14.2. Product Portfolio

            21.3.14.3. Key Financials

            21.3.14.4. SWOT Analysis

            21.3.14.5. Key Developments

            21.3.14.6. Sales Footprint

            21.3.14.7. Strategy Overview

        21.3.15. Pacific Biosciences of California, Inc.

            21.3.15.1. Overview

            21.3.15.2. Product Portfolio

            21.3.15.3. Key Financials

            21.3.15.4. SWOT Analysis

            21.3.15.5. Key Developments

            21.3.15.6. Sales Footprint

            21.3.15.7. Strategy Overview

        21.3.16. Golden Helix, Inc.

            21.3.16.1. Overview

            21.3.16.2. Product Portfolio

            21.3.16.3. Key Financials

            21.3.16.4. SWOT Analysis

            21.3.16.5. Key Developments

            21.3.16.6. Sales Footprint

            21.3.16.7. Strategy Overview

        21.3.17. BioDatomics

            21.3.17.1. Overview

            21.3.17.2. Product Portfolio

            21.3.17.3. Key Financials

            21.3.17.4. SWOT Analysis

            21.3.17.5. Key Developments

            21.3.17.6. Sales Footprint

            21.3.17.7. Strategy Overview

        21.3.18. PierianDx

            21.3.18.1. Overview

            21.3.18.2. Product Portfolio

            21.3.18.3. Key Financials

            21.3.18.4. SWOT Analysis

            21.3.18.5. Key Developments

            21.3.18.6. Sales Footprint

            21.3.18.7. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology

Recommendations

Healthcare

Clinical Oncology Next-generation Sequencing Market

January 2022

REP-GB-9543

May 2024

324 pages

Healthcare

DNA Sequencing Services Market

March 2018

REP-GB-6453

August 2023

306 pages

Healthcare

NGS Sample Preparation Market

May 2017

REP-GB-4047

October 2022

342 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Clinical Next-Generation Sequencing (NGS) Data Analysis Market